Grace Couch
Family · Manning, SCNPI 1821565334
Payments from drug & device makers
Across 19 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$39
- Vanda Pharmaceuticals Inc.$30
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$30
- Bayer$29
- Amgen$29
- Biohaven Pharmaceuticals, Inc.$28
- plus $113 from 8 others
What the payments were for
- Food & beverage$297100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Bayer | 2 | $29 |
| Amgen | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 2 | $28 |
| Antares Pharma, Inc. | 1 | $21 |
| Merck | 1 | $16 |
| Novartis | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Novo Nordisk | 1 | $12 |
| Cequr Corporation | 1 | $8 |
How this compares
$297 in reported general payments places this provider in the 40th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 106 | $951 |
| Azithromycin | 218 | $820 |
| Prednisone | 205 | $792 |
| Oseltamivir Phosphate | 17 | $559 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 61 | $475 |
| Fluconazole | 120 | $412 |
| Mupirocin | 32 | $316 |
| Ondansetron OdtOndansetron | 32 | $301 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 78 | $268 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $257 |
| Diclofenac Potassium | 24 | $204 |
| Cyclobenzaprine Hcl | 44 | $188 |
| Cephalexin | 30 | $181 |
| Ciprofloxacin Hcl | 27 | $140 |
| Levofloxacin | 22 | $120 |
Paid to pharmacies, not to this prescriber.
Other family in Manning
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.